Skip to main content
Top
Published in: BMC Women's Health 1/2024

Open Access 25-01-2024 | Congenital Heart Anomaly | Case Report

Recurrent stroke in a reproductive age women with patent foramen ovale

Authors: Jing Ye, Yujia Yang, Li Tang, Li He, Muke Zhou

Published in: BMC Women's Health | Issue 1/2024

Login to get access

Abstract

Background

Patent foramen ovale (PFO) is a known cause of ischemic stroke in young adults and combined oral contraceptives (COCs) are widely used by women of reproductive age. If young women with PFO are taking COCs, they may be subjected to a synergistic increase in the occurrence of stroke, though reports of ischemic stroke in this population are rare. We report a woman of reproductive age who was taking COC suffered repetitive ischemic strokes before a patent foramen ovale (PFO) was detected and closed, which may raise concerns in this field.

Case presentation

A 31-year-old woman presented to the emergency department with sudden-onset right upper- and lower-limb weakness and dysarthria for 1 hour, whose only risk factor of stroke was oral contraceptive use. On admission, she was alert with left gaze deviation, dysarthria, and right-sided hemiplegia. Her symptoms improved after receiving the revascularization therapy. About 24 hours later, her left eye experienced sudden painless vision loss. Then the PFO with a substantial right-to-left shunt was detected and then she received a trans-catheter closure of the defect. Over 3 months of follow-up, there were no signs of stroke, but visual loss persisted.

Conclusion

This case of disabling stroke raises concerns regarding optimal management in primary and secondary prevention of stroke in young women on COCs with additional risk factors of stroke.
Literature
1.
go back to reference Saver JL, Mattle HP, Thaler D. Patent foramen Ovale closure versus medical therapy for cryptogenic ischemic stroke: a topical review. Stroke. 2018;49:1541–8.CrossRefPubMed Saver JL, Mattle HP, Thaler D. Patent foramen Ovale closure versus medical therapy for cryptogenic ischemic stroke: a topical review. Stroke. 2018;49:1541–8.CrossRefPubMed
3.
go back to reference Carlton C, Banks M, Sundararajan S. Oral contraceptives and ischemic stroke risk. Stroke. 2018;49:e157–9.CrossRefPubMed Carlton C, Banks M, Sundararajan S. Oral contraceptives and ischemic stroke risk. Stroke. 2018;49:e157–9.CrossRefPubMed
4.
go back to reference Plu-Bureau G, Hugon-Rodin J, Maitrot-Mantelet L, Canonico M. Hormonal contraceptives and arterial disease: an epidemiological update. Best Pract Res Clin Endocrinol Metab. 2013;27:35–45.CrossRefPubMed Plu-Bureau G, Hugon-Rodin J, Maitrot-Mantelet L, Canonico M. Hormonal contraceptives and arterial disease: an epidemiological update. Best Pract Res Clin Endocrinol Metab. 2013;27:35–45.CrossRefPubMed
5.
go back to reference Kasner SE, Lattanzi S, Fonseca AC, Elgendy AY. Uncertainties and controversies in the Management of Ischemic Stroke and Transient Ischemic Attack Patients with Patent Foramen Ovale. Stroke. 2021;52:e806–19.CrossRefPubMed Kasner SE, Lattanzi S, Fonseca AC, Elgendy AY. Uncertainties and controversies in the Management of Ischemic Stroke and Transient Ischemic Attack Patients with Patent Foramen Ovale. Stroke. 2021;52:e806–19.CrossRefPubMed
6.
go back to reference Nannoni S, Scherz-Moussa Youma A, Amiguet M, Eskandari A, Strambo D, Michel P. Acute ischaemic stroke in the absence of established vascular risk factors: patient characteristics, stroke mechanism and long-term outcome. Eur J Neurol. 2021;28:1275–83.CrossRefPubMed Nannoni S, Scherz-Moussa Youma A, Amiguet M, Eskandari A, Strambo D, Michel P. Acute ischaemic stroke in the absence of established vascular risk factors: patient characteristics, stroke mechanism and long-term outcome. Eur J Neurol. 2021;28:1275–83.CrossRefPubMed
7.
go back to reference Bousser MG, Conard J, Kittner S, de Lignières B, MacGregor EA, Massiou H, Silberstein SD, Tzourio C. Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. The International Headache Society Task Force on Combined Oral Contraceptives & Hormone Replacement Therapy. Cephalalgia. 2000;20(3):155–6. https://doi.org/10.1046/j.1468-2982.2000.00035.x. Bousser MG, Conard J, Kittner S, de Lignières B, MacGregor EA, Massiou H, Silberstein SD, Tzourio C. Recommendations on the risk of ischaemic stroke associated with use of combined oral contraceptives and hormone replacement therapy in women with migraine. The International Headache Society Task Force on Combined Oral Contraceptives & Hormone Replacement Therapy. Cephalalgia. 2000;20(3):155–6. https://​doi.​org/​10.​1046/​j.​1468-2982.​2000.​00035.​x.
8.
go back to reference Morales Vidal S, Verma G, Goldschmidt C, Biller J. Stroke due to paradoxical embolization related to fibroid uterus enlargement compressing the right common iliac vein. Case Rep Neurol. 2018;10:328–31.CrossRefPubMedPubMedCentral Morales Vidal S, Verma G, Goldschmidt C, Biller J. Stroke due to paradoxical embolization related to fibroid uterus enlargement compressing the right common iliac vein. Case Rep Neurol. 2018;10:328–31.CrossRefPubMedPubMedCentral
Metadata
Title
Recurrent stroke in a reproductive age women with patent foramen ovale
Authors
Jing Ye
Yujia Yang
Li Tang
Li He
Muke Zhou
Publication date
25-01-2024

Other articles of this Issue 1/2024

BMC Women's Health 1/2024 Go to the issue